Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-11-10
DOI
https://doi.org/10.1161/circulationaha.125.077603
Citations
5
Primary Topic
Heart rate and cardiovascular health
Type
article
Field-Weighted Citation Impact
6.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

Kiran Kaur Khush, Kan Saito, Yasuhiro Honda, Cynthia A. Lamendola et al.
5 citations
Circulation
Heart rate and cardiovascular health
6.94
article

Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial

Kiran Kaur Khush, Kan Saito, Yasuhiro Honda, Cynthia A. Lamendola, Akihiro Yoshida, Joshua W. Knowles, Takehiro Hashikata, Brandon Varr, Helen Luikart, Christopher Woo, Jeffrey J. Teuteberg, Annette Skoda, William F. Fearon, Kuniaki Takahashi, Frederik M. Zimmermann, Kosei Terada
article en
5 citations

Abstract

No abstract available for this paper.
CirculationVol. 153(1)
VA Palo Alto Health Care System (US), Cardiovascular Institute of the South (US), St. Antonius Ziekenhuis (NL), Stanford Health Care (US), Kaiser Permanente Santa Clara Medical Center (US), Stanford Medicine (US), Stanford University (US)
Openalex Percentile: Top 3%
Heart rate and cardiovascular health
6.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial — Kiran Kaur Khush, Kan Saito, et al. · Circulation (2025) | TGRS Research Map | TGRS